Cargando…

The Efficacy and Safety of a Fixed Combination of Chinese Herbal Medicine in Chronic Urticaria: A Randomized, Double-Blind, Placebo-Controlled Pilot Study

Background: Chronic urticaria is a bothersome skin disease, and Chinese herbal medicine (CHM) is commonly used as adjuvant therapy. This study aimed to evaluate the effectiveness and safety of the mixture of two CHM formula, Xiao-Feng-San (XFS) and Qing-Shang-Fang-Feng-Tang (QSFFT), in treating urti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Sien-Hung, Lin, Yi-Hsuan, Lin, Jr-Rung, Chen, Hsing-Yu, Hu, Sindy, Yang, Yi-Han, Yang, Yi-Hsun, Yang, Yin-Shuo, Fang, Yao-Fan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305335/ https://www.ncbi.nlm.nih.gov/pubmed/30618764 http://dx.doi.org/10.3389/fphar.2018.01474

Ejemplares similares

Identifying Chinese Herbal Medicine Network for Eczema: Implications from a Nationwide Prescription Database
por: Chen, Hsing-Yu, et al.
Publicado: (2015)

The association between mortality and use of Chinese herbal medicine among incident stage IV esophageal cancer patients: A retrospective cohort study with core herbs exploration
por: Chen, Shu-Ling, et al.
Publicado: (2022)

Tibetan Herbal Pain-Relieving Plaster for Chronic Musculoskeletal Pain Among Cancer Survivors: Study Protocol of a Randomized, Double-Blind, Placebo-Controlled Trial
por: Yang, Mingxiao, et al.
Publicado: (2022)

A Commonly Used Chinese Herbal Formula, Shu-Jing-Hwo-Shiee-Tang, Potentiates Anticoagulant Activity of Warfarin in a Rabbit Model
por: Yang, Sien-Hung, et al.
Publicado: (2013)

The efficacy and safety of concentrated herbal extract granules, YH1, as an add-on medication in poorly controlled type 2 diabetes: A randomized, double-blind, placebo-controlled pilot trial
por: Huang, Yueh-Hsiang, et al.
Publicado: (2019)

Treating acute exacerbations of COPD with Chinese herbal medicine to aid antibiotic use reduction (Excalibur): a randomised double-blind, placebo-controlled feasibility trial
por: Willcox, Merlin L., et al.
Publicado: (2023)

Efficacy and safety of the herbal formula Naesohwajung-tang for functional dyspepsia: a randomized, double-blind, placebo-controlled, multi-center trial
por: Ha, Na-Yeon, et al.
Publicado: (2023)

Identifying Chinese Herbal Medicine Network for Endometriosis: Implications from a Population-Based Database in Taiwan
por: Tsai, Pei-Ju, et al.
Publicado: (2017)

Identifying Core Herbal Treatments for Children with Asthma: Implication from a Chinese Herbal Medicine Database in Taiwan
por: Chen, Hsing-Yu, et al.
Publicado: (2013)

A chinese medicine formula (kunbixiao granule) for female rheumatoid arthritis: Study protocol for a double-blind, randomized, placebo-controlled trial
por: Wan, Yingying, et al.
Publicado: (2022)

Hedyotis diffusa Combined with Scutellaria barbata Are the Core Treatment of Chinese Herbal Medicine Used for Breast Cancer Patients: A Population-Based Study
por: Yeh, Yuan-Chieh, et al.
Publicado: (2014)

Corrigendum: A Chinese medicine formula (kunbixiao granule) for female rheumatoid arthritis: Study protocol for a double-blind, randomized, placebo-controlled trial
por: Wan, Yingying, et al.
Publicado: (2022)

Efficacy and safety of traditional Chinese medicine treatment for idiopathic pulmonary fibrosis: An exploratory, randomized, double-blinded and placebo controlled trial
por: Li, Jiansheng, et al.
Publicado: (2022)

Identifying the Chinese Herbal Medicine Network and Core Formula for Allergic Rhinitis on a Real-World Database
por: Lu, Yen-Chu, et al.
Publicado: (2020)

Comparison of a Chinese Herbal Medicine (CCH1) and Lactulose as First-Line Treatment of Constipation in Long-Term Care: A Randomized, Double-Blind, Double-Dummy, and Placebo-Controlled Trial
por: Huang, Chien-Hsun, et al.
Publicado: (2012)

An Herbal Drug, Gongjin-dan, Ameliorates Acute Fatigue Caused by Short-Term Sleep-Deprivation: A Randomized, Double-Blinded, Placebo-Controlled, Crossover Clinical Trial
por: Son, Mi Ju, et al.
Publicado: (2018)

Chinese Herbal Medicine Combined With EGFR-TKI in EGFR Mutation-Positive Advanced Pulmonary Adenocarcinoma (CATLA): A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
por: Jiao, Lijing, et al.
Publicado: (2019)

Efficacy and safety of a Chinese herbal formula Maxing Ganshi Decoction in children with community-acquired pneumonia: A randomized, double-blind, placebo-controlled, multicenter trial
por: Zheng, Yujiao, et al.
Publicado: (2022)

Associations Between Using Chinese Herbal Medicine and Long-Term Outcome Among Pre-dialysis Diabetic Nephropathy Patients: A Retrospective Population-Based Cohort Study
por: Guo, Jenny Chun-Ling, et al.
Publicado: (2021)

Identifying Chinese herbal medicine for premenstrual syndrome: implications from a nationwide database
por: Chen, Hsing-Yu, et al.
Publicado: (2014)

Herbal Medicine Formulas for Parkinson's Disease: A Systematic Review and Meta-Analysis of Randomized Double-Blind Placebo-Controlled Clinical Trials
por: Shan, Chun-Shuo, et al.
Publicado: (2018)

Effectiveness and safety of Qingfei Dayuan granules for treating influenza and upper respiratory tract infections manifested by the pulmonary heat-toxin syndrome: A multicenter, randomized, double-blind, placebo-controlled trial
por: Li, Weinan, et al.
Publicado: (2023)

Effects of the Chinese herbal formula San-Huang Gu-Ben Zhi-Ke treatment on stable chronic obstructive pulmonary disease: a randomized, double-blind, placebo-controlled trial
por: Lyu, Tianyi, et al.
Publicado: (2023)

Prophylactic Phenylephrine Increases the Dose Requirement of Oxytocin to Treat Uterine Atony During Cesarean Delivery: A Double-Blinded, Single-Center, Randomized and Placebo-Controlled Trial
por: Shen, Yao-Hua, et al.
Publicado: (2021)

Chinese herbal medicine is associated with higher body weight reduction than liraglutide among the obese population: A real-world comparative cohort study
por: Liao, Yu-Ning, et al.
Publicado: (2022)

Corrigendum: Chinese herbal medicine is associated with higher body weight reduction than liraglutide among the obese population: a real-world comparative cohort study
por: Liao, Yu-Ning, et al.
Publicado: (2023)

Chinese Herbal Medicines Have Potentially Beneficial Effects on the Perinatal Outcomes of Pregnant Women
por: Shen, Hsuan-Shu, et al.
Publicado: (2022)

Quanduzhong capsules for the treatment of grade 1 hypertension patients with low-to-moderate risk: A multicenter, randomized, double-blind, placebo-controlled clinical trial
por: Xu, Xuan, et al.
Publicado: (2023)

Efficacy and Safety of Socheongryong-Tang Among Atopic Dermatitis Patients With Respiratory Disorders: A Double-Blinded, Randomized, Placebo-Controlled Clinical Trial
por: Lee, Ju Hyun, et al.
Publicado: (2020)

Efficacy and Safety of GHX02 in the Treatment of Acute Bronchitis and Acute Exacerbation of Chronic Bronchitis: A Phase Ⅱ, Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial
por: Lee, Su Won, et al.
Publicado: (2022)

Herbal Formula SS-1 Increases Tear Secretion for Sjögren’s Syndrome
por: Chang, Ching-Mao, et al.
Publicado: (2021)

Randomized, Double-Blind, Placebo-Controlled Studies of the Safety and Pharmacokinetics of Single and Multiple Ascending Doses of Eravacycline
por: Newman, Joseph V., et al.
Publicado: (2018)

Atovaquone for treatment of COVID-19: A prospective randomized, double-blind, placebo-controlled clinical trial
por: Jain, Mamta K., et al.
Publicado: (2022)

Efficacy of Chinese Herbal Medicine for Diarrhea-Predominant Irritable Bowel Syndrome: A Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled Trials
por: Zhu, Jia-Jie, et al.
Publicado: (2016)

Recent Advances in Herbal Medicines for Digestive System Malignancies
por: Sheng, Jiyao, et al.
Publicado: (2018)

A Randomized, Double-Blind, and Placebo-Controlled Trial of Chinese Herbal Medicine in the Treatment of Childhood Constipation
por: Qiao, Lei, et al.
Publicado: (2021)

First-in-Human, Double-Blind, Randomized, Placebo-Controlled Trial of TQ-F3083, a New Dipeptidyl Peptidase-4 Inhibitor, in Healthy Chinese Adults
por: Liu, Jingrui, et al.
Publicado: (2021)

Lower risk of ischemic stroke among patients with chronic kidney disease using chinese herbal medicine as add-on therapy: A real-world nationwide cohort study
por: Shen, Hsuan-Shu, et al.
Publicado: (2022)

A double-blind, randomized, placebo-controlled, single-center clinical trial of jiaotaiwan for the treatment of insomnia symptoms caused by disharmony of the heart and kidney
por: Xia, Nengzhi, et al.
Publicado: (2022)

Combined effect of traditional Chinese herbal-based formulations Jing Si herbal tea and Jing Si nasal drop inhibits adhesion and transmission of SARS-CoV2 in diabetic SKH-1 mice
por: Chiang, Chien-Yi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lo56uj288ft794t92iugibuuhr